ArticleClinical and molecular hepatology2021

Negligible risk of hepatocellular carcinoma in chronic hepatitis B patients in immune-tolerant phase: Myth or fact.

Terry Cheuk-Fung Yip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.